Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Istanbul - Delayed Quote TRY

MLP Saglik Hizmetleri A.S. (MPARK.IS)

Compare
319.75
+7.75
+(2.48%)
As of 1:52:24 PM GMT+3. Market Open.
Loading Chart for MPARK.IS
  • Previous Close 312.00
  • Open 324.00
  • Bid 319.50 x --
  • Ask 319.75 x --
  • Day's Range 316.00 - 324.00
  • 52 Week Range 197.00 - 422.50
  • Volume 133,118
  • Avg. Volume 524,836
  • Market Cap (intraday) 61.076B
  • Beta (5Y Monthly) -0.02
  • PE Ratio (TTM) 12.50
  • EPS (TTM) 25.58
  • Earnings Date May 26, 2025 - May 30, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 536.79

MLP Saglik Hizmetleri A.S. provides healthcare service in Turkey, Azerbaijan, and Hungary. The company operates hospitals under the Liv Hospital and VM Medical Park names. It also provides treatment, laboratory, ancillary services, as well as trades in medical products. The company serves a range of patients, including middle-upper mass, premium mass, and premium customer segments. The company was formerly known as Medical Park. MLP Saglik Hizmetleri A.S. was founded in 1993 and is based in Istanbul, Turkey.

www.mlpcare.com

13,278

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MPARK.IS

View More

Performance Overview: MPARK.IS

Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is BIST 100 (XU100.IS) .

YTD Return

MPARK.IS
16.30%
BIST 100 (XU100.IS)
3.48%

1-Year Return

MPARK.IS
0.00%
BIST 100 (XU100.IS)
3.32%

3-Year Return

MPARK.IS
876.63%
BIST 100 (XU100.IS)
296.43%

5-Year Return

MPARK.IS
2,304.14%
BIST 100 (XU100.IS)
90.16%

Compare To: MPARK.IS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MPARK.IS

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    59.60B

  • Enterprise Value

    64.86B

  • Trailing P/E

    12.20

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.60

  • Price/Book (mrq)

    2.63

  • Enterprise Value/Revenue

    1.63

  • Enterprise Value/EBITDA

    4.85

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.13%

  • Return on Assets (ttm)

    9.98%

  • Return on Equity (ttm)

    27.45%

  • Revenue (ttm)

    39.69B

  • Net Income Avi to Common (ttm)

    5.21B

  • Diluted EPS (ttm)

    25.58

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.73B

  • Total Debt/Equity (mrq)

    33.95%

  • Levered Free Cash Flow (ttm)

    2.16B

Research Analysis: MPARK.IS

View More

Company Insights: MPARK.IS

Research Reports: MPARK.IS

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.